0
-
10/05/2024 Histocell receives the “Enpresan Bardin” award from CEBEK for its equality policies.On May 8, Histocell received the "Enpresan Bardin" award for its work in equality during...
-
25/01/2024 Histocell obtains AEMPS authorisation and GMP certification for its new manufacturing plant for cell therapy and associated biological medicinal products in Larrabetzu.The biopharmaceutical company reaffirms its commitment to local innovation and manufacturing with the extension of...
-
17/01/2023 Histocell takes part in the new European project NABIHEAL in biomaterials for complex wound healingThe Horizon Europe project NABIHEAL, coordinated by the Center for Biomedical Research Network (CIBER) at...
-
09/01/2023 NABIHEALCURRENT PROJECTS NABIHEAL January 2023 - December 2026 Grant Agreement: 101092269 "ANTIMICROBIAL NANOSTRUCTURED BIOMATERIALS FOR...
-
19/12/2022 Histocell leads ITEAS project: industrial research to boost advanced therapies in the Basque CountryThe ITEAS project investigates advanced therapy drugs to generate new therapeutic strategies for their application...
-
23/11/2022 Japanese company REPROCELL invests in HistocellREPROCELL Inc. decided to invest in Histocell S.L. to strengthen its clinical induced pluripotent stem...
-
14/11/2022 COVICELCall: COVID-19 Reference No.: CO-2020/00003 Project financed by the Department of Economic Development and Infrastructures...
-
01/04/2022 ITEASCURRENT PROJECTS ITEAS April 2022- December 2024 Reference no: ZE-2022/00021 Call: HAZITEK ESTRATEGICO 2022 Project...
-
01/04/2022 PLASMINCURRENT PROJECTS PLASMIN April 2022 - December 2023 Reference No.: ZL-2022/00789 and ZL-2023/00028 Call for...
-
31/05/2021 Cardiva expands its business by acquiring a stake in the biopharmaceutical company HistocellThe company has decided to join one of the most renowned Spanish companies in the...
- 1
- 2